🧠 Rethinking EEG biomarkers.
Lack of disease specificity may not be a weakness of brain biomarkers-it may be exactly what makes them clinically useful.
A transdiagnostic, dimensional perspective could help bridge neuroscience and clinical practice.
rdcu.be/fpUpQ
